VCIM
TSVT

Velan Capital Investment Management’s 2seventy bio TSVT Stock Holding History

Velan Capital Investment Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,657
Closed -$404K – 26
2022
Q1 		$404K Buy
+23,657
New +$401K 0.37% 21

Other funds holding TSVT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Velan Capital Investment Management's TSVT Position: Q2 2022 in Review

Velan Capital Investment Management sold out of 2seventy bio (TSVT) in Q2 2022, closing a stake of 23,657 shares — an estimated $404K sold.

Velan Capital Investment Management first reported a position in TSVT in Q1 2022 and held it in 1 quarter. The position peaked at $404K in Q1 2022. 133 funds tracked by Wall St. Rank hold TSVT as of Q2 2022.

  • Velan Capital Investment Management reported no remaining 2seventy bio position as of Q2 2022 after selling out during the quarter.
  • Velan Capital Investment Management sold 23,657 2seventy bio shares in Q2 2022, an estimated $404K.
  • Velan Capital Investment Management first reported a position in 2seventy bio in Q1 2022 and held it in 1 quarter.
  • Velan Capital Investment Management's 2seventy bio position peaked at $404K in Q1 2022.
  • 133 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2022.

Based on Velan Capital Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.